Safety and Efficacy Study of RT001 to Treat Moderate to Severe Lateral Canthal Lines
Status:
Completed
Trial end date:
2009-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and efficacy of RT001 to treat moderate
to severe lateral canthal lines in adults and duration of effect.